Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
The Human Phenotype Ontology in 2021
Sebastian Koehler et al.
NUCLEIC ACIDS RESEARCH (2021)
Drug target gene-based analyses of drug repositionability in rare and intractable diseases
Ryuichi Sakate et al.
SCIENTIFIC REPORTS (2021)
Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database
Stephanie Nguengang Wakap et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2020)
Orphan drug clinical development
Olivier Blin et al.
THERAPIE (2020)
A genetics-led approach defines the drug target landscape of 30 immune-related traits
Hai Fang et al.
NATURE GENETICS (2019)
Human Disease Ontology 2018 update: classification, content and workflow expansion
Lynn M. Schriml et al.
NUCLEIC ACIDS RESEARCH (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Computational drug repositioning for rare diseases in the era of precision medicine
Brian Delavan et al.
DRUG DISCOVERY TODAY (2018)
A bibliometric review of drug repurposing
Nancy C. Baker et al.
DRUG DISCOVERY TODAY (2018)
Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning
Khader Shameer et al.
BRIEFINGS IN BIOINFORMATICS (2018)
Trends of Clinical Trials for Drug Development in Rare Diseases
Ryuichi Sakate et al.
CURRENT CLINICAL PHARMACOLOGY (2018)
MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search
Noa Rappaport et al.
NUCLEIC ACIDS RESEARCH (2017)
A standard database for drug repositioning
Adam S. Brown et al.
SCIENTIFIC DATA (2017)
A Drug-Centric View of Drug Development: How Drugs Spread from Disease to Disease
Raul Rodriguez-Esteban
PLOS COMPUTATIONAL BIOLOGY (2016)
Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines
Guangxu Jin et al.
DRUG DISCOVERY TODAY (2014)
Transcriptional data: a new gateway to drug repositioning?
Francesco Iorio et al.
DRUG DISCOVERY TODAY (2013)
Rare diseases and orphan drugs
Irena Melnikova
NATURE REVIEWS DRUG DISCOVERY (2012)
A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: Towards a made-in-China orphan drug policy
Bao-cheng Liu et al.
JOURNAL OF PUBLIC HEALTH POLICY (2010)
The human disease network
Kwang-Il Goh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
DrugBank: a comprehensive resource for in silico drug discovery and exploration
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2006)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
